Kano Therapeutics
Signal active
Organization
Contact Information
Overview
N/A
About
Industries
Biotechnology, Health Care, Medical
Founded
2021
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Kano Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $170.4M in funding across 24 round(s). With a team of 1-10 employees, Kano Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - Kano Therapeutics, raised $2.1M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
2
Lead Investors
0
Total Funding Amount
$7.1M
Details
2
Kano Therapeutics has raised a total of $7.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 5.0M | ||
| 2022 | Seed | 2.1M |
Investors
Kano Therapeutics is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Amino Collective | - | FUNDING ROUND - Amino Collective | 2.1M |
| Ann DeWitt | - | FUNDING ROUND - Ann DeWitt | 2.1M |
| Kano Therapeutics | - | FUNDING ROUND - Kano Therapeutics | 2.1M |
| Engine Ventures | - | FUNDING ROUND - Engine Ventures | 2.1M |
Recent Activity
There is no recent news or activity for this profile.